Investors Are Watching: Oracle Corporation (NYSE:ORCL), Hewlett-Packard Company (NYSE:HPQ), Blue Nile Inc. (NASDAQ:NILE), PDL BioPharma (NASDAQ:PDLI), LSI Industries Inc. (NASDAQ:LYTS)


Oracle Corporation (NYSE:ORCL) said it is looking to collaborate with Malaysian organisations to support rising social media usage in local businesses. Oracle Corporation (NYSE:ORCL) in last trading activity advanced 1.75% to close at $41.87. Company weekly performance is 2.32% while its quarterly performance stands at 1.77%. Oracle Corporation (NYSE:ORCL) is -2.48% away from its 52 week high.

On 22 November Hewlett-Packard Company (NYSE:HPQ) said it is moving forward with its plan to split into two companies, and has moved several executives into new roles to execute the plan. On last trading day Hewlett-Packard Company (NYSE:HPQ) advanced 4.07% to close at $39.16. Its volatility for the week is 2.26% while volatility for the month is 1.66%. HPQ’s sales growth for past 5 years was -1.00% and its EPS growth for past 5 years was -4.20%. Hewlett-Packard Company (NYSE:HPQ) monthly performance is 10.19%.

On 30 October Blue Nile Inc. (NASDAQ:NILE) reported financial results for its third quarter ended September 28, 2014. Net sales increased 6.9% to $105.8 million for the third quarter ended September 28, 2014 compared to $98.9 million for the third quarter ended September 29, 2013. Operating income for the quarter totaled $2.6 million, representing an operating margin of 2.4% of net sales, compared to $2.5 million in operating income and 2.5% operating margin for the third quarter of 2013. Net income totaled $1.7 million, or $0.14 per diluted share. On last trading day Blue Nile Inc. (NASDAQ:NILE) decreased -0.20% to close at $34.17. Its volatility for the week is 3.58% while volatility for the month is 3.82%. NILE’s sales growth for past 5 years was 8.80% and its EPS growth for past 5 years was 2.50%. Blue Nile Inc. (NASDAQ:NILE) monthly performance is 11.67%.

On 14 November PDL BioPharma, Inc. (NASDAQ:PDLI) announced that the company has received $30.3 million, in addition to previously received revenue interest payments, to conclude PDL’s revenue interest agreement with AxoGen, Inc. (NASDAQ: AXGN). In October 2012, PDL entered into a structured financing transaction in which PDL provided AxoGen with an aggregate of $20.8 million in exchange for royalties on certain AxoGen revenues. AxoGen is a regenerative medicine company dedicated to advancing the science and commercialization of surgical solutions for peripheral nerve repair. PDL BioPharma, Inc. (NASDAQ:PDLI) has 0.10% insider ownership while its institutional ownership stands at 95.60%. In last trading activity company’s stock closed at $8.14.

LSI Industries Inc (NASDAQ:LYTS) Director Gary P. Kreider acquired 5,000 shares of the stock on the open market in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $6.90 per share, with a total value of $34,500.00. Following the purchase, the director now directly owns 12,679 shares in the company, valued at approximately $87,485. On Wednesday shares of LSI Industries Inc. (NASDAQ:LYTS) closed at $6.91. Company’s sales growth for last 5 years was 5.10% and EPS growth for next 5 years is recorded as 20.00%.


Leave a Reply

Your email address will not be published. Required fields are marked *